Genoskin

Toulouse, France

Genoskin is a biotech company that leverages its expertise in skin biology and immunology to enhance the development of medications.

$5.4M raised

Sep 2025

Series A

Top Investors

BpifranceBNP ParibasCrédit AgricoleCaptech SantéGSO Innovation

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Genoskin raised?

Genoskin has raised $5.4M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are Genoskin's investors?

Genoskin's investors include Bpifrance, BNP Paribas, Crédit Agricole, Captech Santé, GSO Innovation.

Where is Genoskin headquartered?

Genoskin is headquartered in Toulouse, France.

What does Genoskin do?

Genoskin is a biotech company that leverages its expertise in skin biology and immunology to enhance the development of medications.

What stage is Genoskin at?

Genoskin is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 16, 2025.

MLA

"Genoskin — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/genoskin. Accessed June 4, 2026.

APA

VCBacked. (2025). Genoskin — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/genoskin

Wikipedia (cite web)

{{cite web |title=Genoskin — Funding & Investors |url=https://www.vcbacked.co/company/genoskin |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 16, 2025.